Physician profile
Sumit Garg
NPI 1881878262
$807,981.31
in general payments reported to CMS, 2019-2025
35 companies · $179K in 2025
The $179K reported for 2025 was more than what 99% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $160K · 2020: $149K · 2021: $82K · 2022: $104K · 2023: $63K · 2024: $70K · 2025: $179K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $277K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $9,707 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,600 · Travel and Lodging: $4,526 · Honoraria: $626 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $277,316.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,667.50 |
| Food and Beverage | $9,706.80 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,600.00 |
| Travel and Lodging | $4,525.59 |
| Honoraria | $625.59 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $332,659.61 | 2019-2025 | Compact Intuitiv, Intralase Fs Femtosec Laser, Ifs Advanced Femtosec Laser |
| Samsara Vision | $96,511.40 | 2019-2023 | |
| Beaver-Visitec International, INC. | $92,227.10 | 2023-2025 | |
| Allergan, INC. | $41,434.21 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $39,707.50 | 2019-2022 | |
| Sight Sciences, INC. | $34,605.89 | 2019-2025 | Tearcare System, Omni Surgical System, Sion Surgical Instrument |
| Dompe US, INC. | $33,984.77 | 2020-2025 | Oxervate |
| Glaukos Corporation | $28,706.26 | 2019-2025 | Ce-Marked Kxla System, Kxl System, Idose Tr |
| Abbvie INC. | $22,897.29 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $16,338.32 | 2019-2022 | |
| Shire North American Group INC | $12,852.28 | 2019 | |
| Carl Zeiss Meditec, INC. | $12,459.34 | 2019-2025 | Visumax, Callisto Eye, Cirrus Hd-Oct |
| Aerie Pharmaceuticals, INC. | $6,943.80 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $5,355.39 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $4,867.50 | 2024-2025 | Omidria |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $4,360.89 | 2020-2024 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Tarsus Pharmaceuticals, INC. | $3,960.02 | 2024-2025 | Xdemvy |
| Rxsight INC | $2,915.75 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Alcon Vision LLC | $2,434.67 | 2019-2025 | Clareon, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $2,426.61 | 2023-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Eyepoint US, INC. | $1,800.00 | 2019-2020 | |
| Oyster Point Pharma, INC. | $1,782.27 | 2022-2023 | Tyrvaya |
| Hoya Surgical Optics, INC | $1,630.00 | 2023 | Vivinex Gemetric |
| Eyevance Pharmaceuticals LLC | $1,295.09 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $1,222.85 | 2021-2024 | Iolmaster 700, Veracity Surgical, Humphrey Hfa |
| Ivantis, INC | $1,155.34 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $465.76 | 2019-2025 | Xelpros, Cequa, Bromsite |
| Harrow Eye, LLC | $292.02 | 2024-2025 | Vevye |
| Alcon Research LLC | $263.23 | 2024 | Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol |
| Johnson & Johnson Vision Care, INC. | $148.97 | 2022 | |
| Biotissue Holdings INC. | $134.42 | 2025 | |
| Ocular Therapeutix, INC. | $80.14 | 2020 | |
| Thea Pharma INC. | $62.62 | 2025 | Iyuzeh |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$7,861.75 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$60.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.